Titre : Virologie

Virologie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Atrophy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Virologie : Questions médicales les plus fréquentes", "headline": "Virologie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Virologie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Virologie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Microbiologie", "url": "https://questionsmedicales.fr/mesh/D008829", "about": { "@type": "MedicalCondition", "name": "Microbiologie", "code": { "@type": "MedicalCode", "code": "D008829", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "H01.158.273.540" } } }, "about": { "@type": "MedicalCondition", "name": "Virologie", "alternateName": "Virology", "code": { "@type": "MedicalCode", "code": "D014773", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anice C Lowen", "url": "https://questionsmedicales.fr/author/Anice%20C%20Lowen", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA." } }, { "@type": "Person", "name": "Arturo Casadevall", "url": "https://questionsmedicales.fr/author/Arturo%20Casadevall", "affiliation": { "@type": "Organization", "name": "Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA." } }, { "@type": "Person", "name": "Andrew Mehle", "url": "https://questionsmedicales.fr/author/Andrew%20Mehle", "affiliation": { "@type": "Organization", "name": "Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA." } }, { "@type": "Person", "name": "Andrew Pekosz", "url": "https://questionsmedicales.fr/author/Andrew%20Pekosz", "affiliation": { "@type": "Organization", "name": "Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA." } }, { "@type": "Person", "name": "Felicia Goodrum", "url": "https://questionsmedicales.fr/author/Felicia%20Goodrum", "affiliation": { "@type": "Organization", "name": "Department of Immunobiology, University of Arizona, Tucson, Arizona, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders.", "datePublished": "2023-12-18", "url": "https://questionsmedicales.fr/article/38109286", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/alz.13551" } }, { "@type": "ScholarlyArticle", "name": "Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA.", "datePublished": "2023-04-05", "url": "https://questionsmedicales.fr/article/37017707", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13697137.2023.2190508" } }, { "@type": "ScholarlyArticle", "name": "Genetic and clinical landscape of childhood cerebellar hypoplasia and atrophy.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36305856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gim.2022.08.007" } }, { "@type": "ScholarlyArticle", "name": "Treatments for Age-related Vocal Atrophy: A Systematic Review.", "datePublished": "2023-03-13", "url": "https://questionsmedicales.fr/article/36912397", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/lary.30653" } }, { "@type": "ScholarlyArticle", "name": "Sex differences in brain atrophy in dementia with Lewy bodies.", "datePublished": "2023-12-22", "url": "https://questionsmedicales.fr/article/38131463", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/alz.13571" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines des sciences naturelles", "item": "https://questionsmedicales.fr/mesh/D010811" }, { "@type": "ListItem", "position": 3, "name": "Disciplines des sciences biologiques", "item": "https://questionsmedicales.fr/mesh/D001690" }, { "@type": "ListItem", "position": 4, "name": "Biologie", "item": "https://questionsmedicales.fr/mesh/D001695" }, { "@type": "ListItem", "position": 5, "name": "Microbiologie", "item": "https://questionsmedicales.fr/mesh/D008829" }, { "@type": "ListItem", "position": 6, "name": "Virologie", "item": "https://questionsmedicales.fr/mesh/D014773" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Virologie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Virologie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Virologie", "description": "Comment diagnostique-t-on une infection virale ?\nQuels tests sont utilisés pour le VIH ?\nQu'est-ce qu'un test PCR ?\nComment identifier une grippe virale ?\nQuels symptômes indiquent une infection virale ?", "url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Atrophy&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Virologie", "description": "Quels sont les symptômes de l'hépatite virale ?\nComment se manifeste le COVID-19 ?\nQuels signes d'infection par le virus de la varicelle ?\nQuels symptômes d'une infection à rhinovirus ?\nQuels symptômes d'une infection par le virus Ebola ?", "url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Atrophy&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Virologie", "description": "Comment prévenir l'infection par le VIH ?\nQuelles vaccins pour prévenir la grippe ?\nComment éviter la transmission du COVID-19 ?\nQuelles mesures pour prévenir l'hépatite A ?\nComment prévenir la varicelle ?", "url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Atrophy&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Virologie", "description": "Quels traitements pour le VIH ?\nComment traiter une grippe ?\nY a-t-il un traitement pour l'hépatite C ?\nComment traiter une infection à coronavirus ?\nQuels sont les traitements pour la varicelle ?", "url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Atrophy&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Virologie", "description": "Quelles complications de l'hépatite B ?\nQuelles complications du virus Ebola ?\nQuels risques liés à la grippe ?\nQuelles complications du COVID-19 ?\nQuelles complications de la varicelle ?", "url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Atrophy&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Virologie", "description": "Quels sont les facteurs de risque pour le VIH ?\nQui est à risque de grippe sévère ?\nQuels facteurs augmentent le risque d'hépatite C ?\nQuels sont les facteurs de risque pour le COVID-19 ?\nQui est à risque de varicelle ?", "url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Atrophy&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une infection virale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests PCR, sérologiques et parfois des cultures virales." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le VIH ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de dépistage incluent les tests ELISA et les tests de charge virale." } }, { "@type": "Question", "name": "Qu'est-ce qu'un test PCR ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "C'est un test qui amplifie l'ADN viral pour détecter la présence de virus." } }, { "@type": "Question", "name": "Comment identifier une grippe virale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests rapides et des cultures de virus peuvent confirmer une grippe." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection virale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, douleurs musculaires et symptômes respiratoires sont courants." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hépatite virale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Jaunisse, fatigue, douleurs abdominales et perte d'appétit sont fréquents." } }, { "@type": "Question", "name": "Comment se manifeste le COVID-19 ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, toux, essoufflement et perte de goût sont des symptômes clés." } }, { "@type": "Question", "name": "Quels signes d'infection par le virus de la varicelle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Éruption cutanée, démangeaisons et fièvre sont typiques de la varicelle." } }, { "@type": "Question", "name": "Quels symptômes d'une infection à rhinovirus ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Congestion nasale, éternuements et maux de gorge sont courants." } }, { "@type": "Question", "name": "Quels symptômes d'une infection par le virus Ebola ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, vomissements, diarrhée et hémorragies peuvent se manifester." } }, { "@type": "Question", "name": "Comment prévenir l'infection par le VIH ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des préservatifs et des traitements prophylactiques comme le PrEP." } }, { "@type": "Question", "name": "Quelles vaccins pour prévenir la grippe ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le vaccin antigrippal est recommandé chaque année pour réduire le risque." } }, { "@type": "Question", "name": "Comment éviter la transmission du COVID-19 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Porter un masque, se laver les mains et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "Quelles mesures pour prévenir l'hépatite A ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Vaccination et hygiène alimentaire sont cruciales pour prévenir l'hépatite A." } }, { "@type": "Question", "name": "Comment prévenir la varicelle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination est le moyen le plus efficace de prévenir la varicelle." } }, { "@type": "Question", "name": "Quels traitements pour le VIH ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antirétroviraux sont utilisés pour contrôler l'infection par le VIH." } }, { "@type": "Question", "name": "Comment traiter une grippe ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux comme l'oseltamivir peuvent réduire la durée des symptômes." } }, { "@type": "Question", "name": "Y a-t-il un traitement pour l'hépatite C ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antiviraux à action directe peuvent guérir l'hépatite C." } }, { "@type": "Question", "name": "Comment traiter une infection à coronavirus ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des antiviraux et des soins de soutien selon la gravité." } }, { "@type": "Question", "name": "Quels sont les traitements pour la varicelle ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des antihistaminiques et des antiviraux peuvent soulager les symptômes." } }, { "@type": "Question", "name": "Quelles complications de l'hépatite B ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Cirrhose et cancer du foie peuvent survenir chez les patients chroniques." } }, { "@type": "Question", "name": "Quelles complications du virus Ebola ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles hémorragiques et des défaillances organiques." } }, { "@type": "Question", "name": "Quels risques liés à la grippe ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des pneumonies et des exacerbations d'asthme peuvent survenir chez les vulnérables." } }, { "@type": "Question", "name": "Quelles complications du COVID-19 ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des problèmes respiratoires chroniques et des troubles neurologiques peuvent apparaître." } }, { "@type": "Question", "name": "Quelles complications de la varicelle ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Infections bactériennes secondaires et pneumonie peuvent survenir chez les adultes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour le VIH ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les rapports non protégés et l'utilisation de drogues injectables augmentent le risque." } }, { "@type": "Question", "name": "Qui est à risque de grippe sévère ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées, les jeunes enfants et les immunodéprimés sont plus à risque." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'hépatite C ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation de drogues injectables et les transfusions sanguines non sécurisées sont des risques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour le COVID-19 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et l'obésité augmentent le risque de complications." } }, { "@type": "Question", "name": "Qui est à risque de varicelle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes non vaccinées et celles ayant un système immunitaire affaibli sont à risque." } } ] } ] }

Sources (3041 au total)

Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders.

Associations of cerebellar atrophy with specific neuropathologies in Alzheimer's disease and related dementias (ADRD) have not been systematically analyzed. This study examined cerebellar gray matter ... Cerebellar gray matter volume was examined using voxel-based morphometry in 309 autopsy-proven ADRD cases and 80 healthy controls. ADRD subtypes included AD, mixed Lewy body disease and AD (LBD-AD), a... Distinct patterns of cerebellar atrophy were observed in all ADRD subtypes. Significant cerebellar gray matter changes appeared in the early stages of most subtypes and the very early stages of AD, LB... Our findings establish pathology-specific profiles of cerebellar atrophy in ADRD and propose cerebellar neuroimaging as a non-invasive biomarker for differential diagnosis and disease monitoring.... Cerebellar atrophy was examined in 309 patients with autopsy-proven neurodegeneration. Distinct patterns of cerebellar atrophy are found in all pathological subtypes of Alzheimer's disease and related...

Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA.

This study aimed to evaluate the self-reported satisfaction of Spanish postmenopausal women currently treated for vulvovaginal atrophy (VVA) symptoms.... The CRETA (CRoss sectional European sTudy on Adherence) is a multicenter cross-sectional study conducted in 29 public and private hospitals in Spain, which enrolled postmenopausal women receiving trea... Among 752 women who completed the survey, the satisfaction score was significantly higher for the group treated with ospemifene (mean 8.3 ± 1.4) compared with the local HT group (7.2 ± 1.7) and the va... Among postmenopausal women with VVA, treatment with ospemifene has the most positive perceptions and the highest overall satisfaction level and could be an optimal therapeutic approach, maximizing pat...

Genetic and clinical landscape of childhood cerebellar hypoplasia and atrophy.

Cerebellar hypoplasia and atrophy (CBHA) in children is an extremely heterogeneous group of disorders, but few comprehensive genetic studies have been reported. Comprehensive genetic analysis of CBHA ... Patients with CBHA in 176 families were genetically examined using exome sequencing. Patients with disease-causing variants were clinically evaluated.... Disease-causing variants were identified in 96 of the 176 families (54.5%). After excluding 6 families, 48 patients from 42 families were categorized as having syndromic associations with CBHA, wherea... A wide genetic and clinical diversity of CBHA was revealed through exome sequencing in this cohort, which highlights the importance of comprehensive genetic analyses. Furthermore, molecular-based trea...

Treatments for Age-related Vocal Atrophy: A Systematic Review.

Age-related vocal atrophy (ARVA) can dramatically affect voice, communication, and quality of life. The objectives of this systematic review were to (1) determine whether treatments for ARVA were supe... The literature was searched using strategies designed by a medical librarian (2/18/21, updated 3/9/22). Studies investigating treatments for bilateral vocal atrophy were included. Studies involving un... After applying the inclusion/exclusion criteria, 8 articles remained, including 4 randomized trials and 4 cohort studies, and a narrative synthesis was performed. Surgical and behavioral treatments fo... When comparing treatments for ARVA. Surgery and voice therapy were both superior to control groups based on specific outcome measures from different domains. Superiority of one treatment could not be ... N/A Laryngoscope, 133:2846-2855, 2023....

Sex differences in brain atrophy in dementia with Lewy bodies.

Sex influences neurodegeneration, but it has been poorly investigated in dementia with Lewy bodies (DLB). We investigated sex differences in brain atrophy in DLB using magnetic resonance imaging (MRI)... We included 436 patients from the European-DLB consortium and the Mayo Clinic. Sex differences and sex-by-age interactions were assessed through visual atrophy rating scales (n = 327; 73 ± 8 years, 62... We found a higher likelihood of frontal atrophy and smaller volumes in six cortical regions in males and thinner olfactory cortices in females. There were significant sex-by-age interactions in volume... We demonstrate that males have more widespread cortical atrophy at younger ages, but differences tend to disappear with increasing age, with males and females converging around the age of 75.... Male DLB patients had higher odds for frontal atrophy on radiological visual rating scales. Male DLB patients displayed a widespread pattern of cortical gray matter alterations on automated methods. S...

Vulvovaginal atrophy in the CRETA study: the healthcare professionals' perception.

The objective is to assess the perception of gynecologists regarding patients' adherence to vulvovaginal atrophy (VVA) treatments, to evaluate the gynecologists' opinions on what their patients think ... Spanish gynecologists who participated in the CRETA study were asked to fill out an online 41-item questionnaire to evaluate their views on VVA management.... From 29 centers across Spain, 44 gynecologists completed the survey. Their mean age was 47.2 years old, two-thirds of them were women, and the average professional experience was over 20 years. Accord... Spanish gynecologists are in general agreement with their patients regarding VVA treatment preferences and the main issues for adherence and effectiveness. However, there is an opportunity for doctor-...

New developments in the management of vulvovaginal atrophy: a comprehensive overview.

Proper recognition and individualized therapy of vulvovaginal atrophy (VVA) is paramount.... Assessment of VVA should be performed using several questionnaires in combination with wet mount microscopy to determine Vaginal Cell Maturation Index (VCMI) and infections. PubMed searches were carri... Proper treatment is not possible without a correct and full diagnosis, including microscopy of the vaginal fluid. Low dose vaginal estrogen treatment, especially with estriol, is very efficient and is...

Grey matter atrophy in patients with benign multiple sclerosis.

Brain atrophy appears during the progression of multiple sclerosis (MS) and is associated with the disability caused by the disease.... We investigated global and regional grey matter (GM) and white matter (WM) volumes, WM lesion load, and corpus callosum index (CCI), in benign relapsing-remitting MS (BRRMS, n = 35) with and without a... The total brain and cerebral WM volumes were larger in BRRMS than in ARRMS (p = .014, p = .017 respectively). In BRRMS, total brain volumes, regional GM volumes, and CCI were found similar whether or ... Thalamic volume is the most prominent measure to differentiate BRRMS and ARRMS. Validation of automated quantification of CCI provides an additional applicable MRI biomarker to detect brain atrophy in...

The correlation of atrophy, traction and neovascularization in myopic choroidal neovascularization according to a novel myopic maculopathy classification system (atrophy (A), traction (T), neovascularization (N): ATN).

To grade myopic choroidal neovascularization (CNV) patients according to the new myopic maculopathy classification (A: atrophy, T: traction, N: neovascularization-ATN) and analyze the correlation in b... Fifty-one eyes of 41 patients with the diagnosis of pathologic myopia and myopic CNV were included in this clinical practice study. Patients were graded according to the recently described ATN classif... Active myopic CNV was observed most frequently in the group with patchy chorioretinal atrophy. Grade of the atrophy and female gender were significantly associated with myopic CNV scar in the univaria... ATN classification is a practical and comprehensive system to grade myopic CNV. Atrophy is an independent predictor for myopic CNV scar and patchy chorioretinal atrophy requires a more careful examina...